Honigman's COO Robert D. Kubic named one of Corp! Magazine's “Michigan Top Executives”
Honigman Miller Schwartz and Cohn LLP (Honigman) is pleased to announce that its Chief Operating Officer Robert D. Kubic has been selected as one of Corp! magazine’s 2010 “Michigan Top Executives.” Corp! magazine identified 21 leaders throughout the state who are driving innovation, bringing business to Michigan and generally making business happen here, even in this challenging economy. According to the magazine, the primary attribute shared by these leaders is that they are all determined and committed to finding business success in Michigan.
Kubic came to Honigman in November 2008 from Mintz Levin, a national law firm based in Boston. He has more than 20 years of experience in the legal service industry. At Honigman, Kubic serves as a member of its Senior Management Team.
Kubic earned an MBA from Weatherhead School of Management at Case Western Reserve University and a B.A. from Hiram (Ohio) College.
Kubic is active in the Fibromuscular Dysplasia Society of America, Inc. (FMDSA). The nonprofit organization is dedicated to increasing the understanding of Fibromuscular Dysplasia (FMD) among doctors and patients and improving the lives of people with this condition. FMD, an under-diagnosed disease in which abnormal cells develop in the arteries causing a decrease in blood flow, captured the attention of the Wall Street Journal in June 2009. The article quoted Thom W. Rooke, vascular medicine professor at the Mayo Clinic, as estimating “three to five percent would be a very reasonable estimate in the general population for FMD.” Through the work of FMDSA, the University of Michigan recently joined eight other sites throughout the world, including prestigious institutions such as the Cleveland Clinic, the Mayo Clinic and Mt. Sinai in New York, in registering patients in a database to collect important information about the disease. The data for all sites is being hosted at the University of Michigan and is being used to assist in better diagnosis and treatment of FMD.